TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global and United States Molecular Diagnostics in Infectious Disease Testing Market Report & Forecast 2022-2028

Global and United States Molecular Diagnostics in Infectious Disease Testing Market Report & Forecast 2022-2028

  • Category:Life Sciences
  • Published on : 13 October 2022
  • Pages :103
  • Formats:
  • Report Code:SMR-7437250
OfferClick for best price

Best Price: $3480

Molecular DiagnosticsInfectious Disease Testing Market Size, Share 2022


Market Analysis and Insights: Global Molecular DiagnosticsInfectious Disease Testing Market

The global Molecular DiagnosticsInfectious Disease Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Molecular DiagnosticsInfectious Disease Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Molecular DiagnosticsInfectious Disease Testing market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Molecular DiagnosticsInfectious Disease Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Molecular DiagnosticsInfectious Disease Testing market.

Global Molecular DiagnosticsInfectious Disease Testing Scope and Market Size

Molecular Diagnostics in Infectious Disease Testing market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Molecular Diagnostics in Infectious Disease Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Molecular Diagnostics in Infectious Disease Testing market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type

Polymerase Chain Reaction (PCR)

Isothermal Nucleic Acid Amplification Technology (INAAT)

Microarrays

Next-Generation Sequencing (NGS)

Hybridization

Others

Segment by Application

Hospitals

Clinics

Academic Institutes

Laboratories

Others

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

By Company

Abbott

BD

BioMerieux

Thermo Fisher Scientific

Roche

Siemens

Veridex

Luminex

GenMark Diagnostics

Qiagen

Genomix Biotech

BioTheranostics

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Molecular DiagnosticsInfectious Disease Testing product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Molecular DiagnosticsInfectious Disease Testing, with price, sales, revenue, and global market share of Molecular DiagnosticsInfectious Disease Testing from 2019 to 2022.

Chapter 3, the Molecular DiagnosticsInfectious Disease Testing competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Molecular DiagnosticsInfectious Disease Testing breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Molecular DiagnosticsInfectious Disease Testing market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Molecular DiagnosticsInfectious Disease Testing.

Chapter 13, 14, and 15, to describe Molecular DiagnosticsInfectious Disease Testing sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Molecular DiagnosticsInfectious Disease Testing Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global and United States Molecular Diagnostics in Infectious Disease Testing Market Report & Forecast 2022-2028
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 103 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Study Coverage
1.1 Molecular Diagnostics in Infectious Disease Testing Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million) Introduction
1.2 Global Molecular Diagnostics in Infectious Disease Testing Outlook 2017 VS 2022 VS 2028
1.2.1 Global Molecular Diagnostics in Infectious Disease Testing Market Size for the Year 2017-2028
1.2.2 Global Molecular Diagnostics in Infectious Disease Testing Market Size for the Year 2017-2028
1.3 Molecular Diagnostics in Infectious Disease Testing Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Molecular Diagnostics in Infectious Disease Testing in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Molecular Diagnostics in Infectious Disease Testing Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Molecular Diagnostics in Infectious Disease Testing Market Dynamics
1.4.1 Molecular Diagnostics in Infectious Disease Testing Industry Trends
1.4.2 Molecular Diagnostics in Infectious Disease Testing Market Drivers
1.4.3 Molecular Diagnostics in Infectious Disease Testing Market Challenges
1.4.4 Molecular Diagnostics in Infectious Disease Testing Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Molecular Diagnostics in Infectious Disease Testing by Type
2.1 Molecular Diagnostics in Infectious Disease Testing Market Segment by Type
2.1.1 Polymerase Chain Reaction (PCR)
2.1.2 Isothermal Nucleic Acid Amplification Technology (INAAT)
2.1.3 Microarrays
2.1.4 Next-Generation Sequencing (NGS)
2.1.5 Hybridization
2.1.6 Others
2.2 Global Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2017, 2022 & 2028)
2.3 Global Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2017-2028)
2.4 United States Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2017, 2022 & 2028)
2.5 United States Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2017-2028)
3 Molecular Diagnostics in Infectious Disease Testing by Application
3.1 Molecular Diagnostics in Infectious Disease Testing Market Segment by Application
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Academic Institutes
3.1.4 Laboratories
3.1.5 Others
3.2 Global Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2017, 2022 & 2028)
3.3 Global Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2017-2028)
3.4 United States Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2017, 2022 & 2028)
3.5 United States Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2017-2028)
4 Global Molecular Diagnostics in Infectious Disease Testing Competitor Landscape by Company
4.1 Global Molecular Diagnostics in Infectious Disease Testing Market Size by Company
4.1.1 Top Global Molecular Diagnostics in Infectious Disease Testing Companies Ranked by Revenue (2021)
4.1.2 Global Molecular Diagnostics in Infectious Disease Testing Revenue by Player (2017-2022)
4.2 Global Molecular Diagnostics in Infectious Disease Testing Concentration Ratio (CR)
4.2.1 Molecular Diagnostics in Infectious Disease Testing Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Molecular Diagnostics in Infectious Disease Testing in 2021
4.2.3 Global Molecular Diagnostics in Infectious Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Molecular Diagnostics in Infectious Disease Testing Headquarters, Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million) Type
4.3.1 Global Molecular Diagnostics in Infectious Disease Testing Headquarters and Area Served
4.3.2 Global Molecular Diagnostics in Infectious Disease Testing Companies Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Molecular Diagnostics in Infectious Disease Testing Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Molecular Diagnostics in Infectious Disease Testing Market Size by Company
4.5.1 Top Molecular Diagnostics in Infectious Disease Testing Players in United States, Ranked by Revenue (2021)
4.5.2 United States Molecular Diagnostics in Infectious Disease Testing Revenue by Players (2020, 2021 & 2022)
5 Global Molecular Diagnostics in Infectious Disease Testing Market Size by Region
5.1 Global Molecular Diagnostics in Infectious Disease Testing Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Molecular Diagnostics in Infectious Disease Testing Market Size by Region (2017-2028)
5.2.1 Global Molecular Diagnostics in Infectious Disease Testing Market Size by Region: 2017-2022
5.2.2 Global Molecular Diagnostics in Infectious Disease Testing Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth 2017-2028
6.1.2 North America Molecular Diagnostics in Infectious Disease Testing Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth 2017-2028
6.3.2 Europe Molecular Diagnostics in Infectious Disease Testing Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth 2017-2028
6.4.2 Latin America Molecular Diagnostics in Infectious Disease Testing Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Abbott
7.1.1 Abbott Company Details
7.1.2 Abbott Business Overview
7.1.3 Abbott Molecular Diagnostics in Infectious Disease Testing Introduction
7.1.4 Abbott Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
7.1.5 Abbott Recent Development
7.2 BD
7.2.1 BD Company Details
7.2.2 BD Business Overview
7.2.3 BD Molecular Diagnostics in Infectious Disease Testing Introduction
7.2.4 BD Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
7.2.5 BD Recent Development
7.3 BioMerieux
7.3.1 BioMerieux Company Details
7.3.2 BioMerieux Business Overview
7.3.3 BioMerieux Molecular Diagnostics in Infectious Disease Testing Introduction
7.3.4 BioMerieux Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
7.3.5 BioMerieux Recent Development
7.4 Thermo Fisher Scientific
7.4.1 Thermo Fisher Scientific Company Details
7.4.2 Thermo Fisher Scientific Business Overview
7.4.3 Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Introduction
7.4.4 Thermo Fisher Scientific Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
7.4.5 Thermo Fisher Scientific Recent Development
7.5 Roche
7.5.1 Roche Company Details
7.5.2 Roche Business Overview
7.5.3 Roche Molecular Diagnostics in Infectious Disease Testing Introduction
7.5.4 Roche Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
7.5.5 Roche Recent Development
7.6 Siemens
7.6.1 Siemens Company Details
7.6.2 Siemens Business Overview
7.6.3 Siemens Molecular Diagnostics in Infectious Disease Testing Introduction
7.6.4 Siemens Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
7.6.5 Siemens Recent Development
7.7 Veridex
7.7.1 Veridex Company Details
7.7.2 Veridex Business Overview
7.7.3 Veridex Molecular Diagnostics in Infectious Disease Testing Introduction
7.7.4 Veridex Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
7.7.5 Veridex Recent Development
7.8 Luminex
7.8.1 Luminex Company Details
7.8.2 Luminex Business Overview
7.8.3 Luminex Molecular Diagnostics in Infectious Disease Testing Introduction
7.8.4 Luminex Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
7.8.5 Luminex Recent Development
7.9 GenMark Diagnostics
7.9.1 GenMark Diagnostics Company Details
7.9.2 GenMark Diagnostics Business Overview
7.9.3 GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Introduction
7.9.4 GenMark Diagnostics Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
7.9.5 GenMark Diagnostics Recent Development
7.10 Qiagen
7.10.1 Qiagen Company Details
7.10.2 Qiagen Business Overview
7.10.3 Qiagen Molecular Diagnostics in Infectious Disease Testing Introduction
7.10.4 Qiagen Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
7.10.5 Qiagen Recent Development
7.11 Genomix Biotech
7.11.1 Genomix Biotech Company Details
7.11.2 Genomix Biotech Business Overview
7.11.3 Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Introduction
7.11.4 Genomix Biotech Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
7.11.5 Genomix Biotech Recent Development
7.12 BioTheranostics
7.12.1 BioTheranostics Company Details
7.12.2 BioTheranostics Business Overview
7.12.3 BioTheranostics Molecular Diagnostics in Infectious Disease Testing Introduction
7.12.4 BioTheranostics Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
7.12.5 BioTheranostics Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Molecular Diagnostics in Infectious Disease Testing Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Molecular Diagnostics in Infectious Disease Testing Market Trends
Table 3. Molecular Diagnostics in Infectious Disease Testing Market Drivers
Table 4. Molecular Diagnostics in Infectious Disease Testing Market Challenges
Table 5. Molecular Diagnostics in Infectious Disease Testing Market Restraints
Table 6. Global Molecular Diagnostics in Infectious Disease Testing Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Molecular Diagnostics in Infectious Disease Testing Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Molecular Diagnostics in Infectious Disease Testing Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Molecular Diagnostics in Infectious Disease Testing Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Molecular Diagnostics in Infectious Disease Testing Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Molecular Diagnostics in Infectious Disease Testing Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Molecular Diagnostics in Infectious Disease Testing Revenue Share by Player, 2017-2022
Table 13. Global Molecular Diagnostics in Infectious Disease Testing Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Molecular Diagnostics in Infectious Disease Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostics in Infectious Disease Testing as of 2021)
Table 15. Top Players of Molecular Diagnostics in Infectious Disease Testing in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Molecular Diagnostics in Infectious Disease Testing Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Molecular Diagnostics in Infectious Disease Testing Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Molecular Diagnostics in Infectious Disease Testing Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Molecular Diagnostics in Infectious Disease Testing Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Molecular Diagnostics in Infectious Disease Testing Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Molecular Diagnostics in Infectious Disease Testing Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Molecular Diagnostics in Infectious Disease Testing Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Molecular Diagnostics in Infectious Disease Testing Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Molecular Diagnostics in Infectious Disease Testing Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Molecular Diagnostics in Infectious Disease Testing Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Molecular Diagnostics in Infectious Disease Testing Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. Abbott Company Details
Table 31. Abbott Business Overview
Table 32. Abbott Molecular Diagnostics in Infectious Disease Testing Product
Table 33. Abbott Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 34. Abbott Recent Development
Table 35. BD Company Details
Table 36. BD Business Overview
Table 37. BD Molecular Diagnostics in Infectious Disease Testing Product
Table 38. BD Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 39. BD Recent Development
Table 40. BioMerieux Company Details
Table 41. BioMerieux Business Overview
Table 42. BioMerieux Molecular Diagnostics in Infectious Disease Testing Product
Table 43. BioMerieux Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 44. BioMerieux Recent Development
Table 45. Thermo Fisher Scientific Company Details
Table 46. Thermo Fisher Scientific Business Overview
Table 47. Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Product
Table 48. Thermo Fisher Scientific Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 49. Thermo Fisher Scientific Recent Development
Table 50. Roche Company Details
Table 51. Roche Business Overview
Table 52. Roche Molecular Diagnostics in Infectious Disease Testing Product
Table 53. Roche Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 54. Roche Recent Development
Table 55. Siemens Company Details
Table 56. Siemens Business Overview
Table 57. Siemens Molecular Diagnostics in Infectious Disease Testing Product
Table 58. Siemens Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 59. Siemens Recent Development
Table 60. Veridex Company Details
Table 61. Veridex Business Overview
Table 62. Veridex Molecular Diagnostics in Infectious Disease Testing Product
Table 63. Veridex Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 64. Veridex Recent Development
Table 65. Luminex Company Details
Table 66. Luminex Business Overview
Table 67. Luminex Molecular Diagnostics in Infectious Disease Testing Product
Table 68. Luminex Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 69. Luminex Recent Development
Table 70. GenMark Diagnostics Company Details
Table 71. GenMark Diagnostics Business Overview
Table 72. GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Product
Table 73. GenMark Diagnostics Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 74. GenMark Diagnostics Recent Development
Table 75. Qiagen Company Details
Table 76. Qiagen Business Overview
Table 77. Qiagen Molecular Diagnostics in Infectious Disease Testing Product
Table 78. Qiagen Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 79. Qiagen Recent Development
Table 80. Genomix Biotech Company Details
Table 81. Genomix Biotech Business Overview
Table 82. Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Product
Table 83. Genomix Biotech Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 84. Genomix Biotech Recent Development
Table 85. BioTheranostics Company Details
Table 86. BioTheranostics Business Overview
Table 87. BioTheranostics Molecular Diagnostics in Infectious Disease Testing Product
Table 88. BioTheranostics Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 89. BioTheranostics Recent Development
Table 90. Research Programs/Design for This Report
Table 91. Key Data Information from Secondary Sources
Table 92. Key Data Information from Primary Sources
List of Figures
Figure 1. Molecular Diagnostics in Infectious Disease Testing Product Picture
Figure 2. Global Molecular Diagnostics in Infectious Disease Testing Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Molecular Diagnostics in Infectious Disease Testing Market Size 2017-2028 (US$ Million)
Figure 4. United States Molecular Diagnostics in Infectious Disease Testing Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Molecular Diagnostics in Infectious Disease Testing Market Size 2017-2028 (US$ Million)
Figure 6. United States Molecular Diagnostics in Infectious Disease Testing Market Share in Global 2017-2028
Figure 7. Molecular Diagnostics in Infectious Disease Testing Report Years Considered
Figure 8. Product Picture of Polymerase Chain Reaction (PCR)
Figure 9. Product Picture of Isothermal Nucleic Acid Amplification Technology (INAAT)
Figure 10. Product Picture of Microarrays
Figure 11. Product Picture of Next-Generation Sequencing (NGS)
Figure 12. Product Picture of Hybridization
Figure 13. Product Picture of Others
Figure 14. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Type in 2022 & 2028
Figure 15. Global Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2017-2028) & (US$ Million)
Figure 16. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Type (2017-2028)
Figure 17. United States Molecular Diagnostics in Infectious Disease Testing Market Share by Type in 2022 & 2028
Figure 18. United States Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2017-2028) & (US$ Million)
Figure 19. United States Molecular Diagnostics in Infectious Disease Testing Market Share by Type (2017-2028)
Figure 20. Product Picture of Hospitals
Figure 21. Product Picture of Clinics
Figure 22. Product Picture of Academic Institutes
Figure 23. Product Picture of Laboratories
Figure 24. Product Picture of Others
Figure 25. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Application in 2022 & 2028
Figure 26. Global Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2017-2028) & (US$ Million)
Figure 27. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Application (2017-2028)
Figure 28. United States Molecular Diagnostics in Infectious Disease Testing Market Share by Application in 2022 & 2028
Figure 29. United States Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2017-2028) & (US$ Million)
Figure 30. United States Molecular Diagnostics in Infectious Disease Testing Market Share by Application (2017-2028)
Figure 31. North America Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate 2017-2028 (US$ Million)
Figure 32. U.S. Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. Canada Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. Europe Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate 2017-2028 (US$ Million)
Figure 35. Germany Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 36. France Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 37. U.K. Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 38. Italy Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. Russia Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate 2017-2028 (US$ Million)
Figure 41. China Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. Japan Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. South Korea Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. India Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Australia Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 46. Taiwan Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 47. Indonesia Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 48. Thailand Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 49. Malaysia Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 50. Philippines Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 51. Latin America Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate 2017-2028 (US$ Million)
Figure 52. Mexico Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 53. Brazil Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 54. Argentina Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 55. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate 2017-2028 (US$ Million)
Figure 56. Turkey Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 57. Saudi Arabia Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 58. UAE Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 59. Abbott Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
Figure 60. BD Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
Figure 61. BioMerieux Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
Figure 62. Thermo Fisher Scientific Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
Figure 63. Roche Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
Figure 64. Siemens Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
Figure 65. Veridex Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
Figure 66. Luminex Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
Figure 67. GenMark Diagnostics Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
Figure 68. Qiagen Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
Figure 69. Genomix Biotech Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
Figure 70. BioTheranostics Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount